Security key
45257U108
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)
CUSIP: 45257U108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 113,446,633
- Total 13F shares
- 79,431,966
- Share change
- +2,485,143
- Total reported value
- $738,692,421
- Put/Call ratio
- 9440%
- Price per share
- $9.30
- Number of holders
- 142
- Value change
- +$30,839,753
- Number of buys
- 81
- Number of sells
- 64
Report period
Q2 2025
Institutions
142
Top holders
10
IMNM full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Immunome Inc. SEC filings
Immunome Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45257U108
Recent filing periods:
Top shareholders of IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Immunome Aggregator, LP |
13D/G
|
— |
6%
|
4,768,583
|
$40,628,327 | $0 | 31 Jan 2025 | |
| EcoR1 Capital, LLC |
13D/G
13F
|
Company |
4.7%
|
4,079,415
|
$34,756,616 | $0 | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
2.2%
|
1,914,758
|
$16,313,738 | -$13,130,862 | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
6.7%
|
7,554,594
|
$50,843,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
5%
|
5,662,699
|
$38,109,966 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
4.7%
|
5,361,187
|
$36,080,789 | — | 31 Mar 2025 | |
| Enavate Sciences GP, LLC |
13F
|
Company |
4.2%
|
4,768,583
|
$32,092,564 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.8%
|
4,360,675
|
$29,347,343 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
4,307,191
|
$28,987,396 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
3.4%
|
3,892,318
|
$26,195,300 | — | 31 Mar 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
3.1%
|
3,550,000
|
$23,891,500 | — | 31 Mar 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
3%
|
3,413,700
|
$22,974,201 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
3,069,607
|
$20,660,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
2,640,443
|
$17,770,181 | — | 31 Mar 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
2%
|
2,288,000
|
$15,398,240 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,743,057
|
$11,733,503 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,657,729
|
$11,156,516 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.4%
|
1,610,708
|
$10,840,066 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.2%
|
1,377,053
|
$9,267,567 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.76%
|
864,223
|
$5,816,221 | — | 31 Mar 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.7%
|
788,666
|
$5,307,722 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.68%
|
775,000
|
$5,215,750 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.66%
|
750,000
|
$5,047,500 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
698,401
|
$4,700,239 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.55%
|
619,538
|
$4,169,490 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.54%
|
614,387
|
$4,134,825 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.54%
|
610,551
|
$4,109,008 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.53%
|
606,762
|
$4,083,508 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
461,059
|
$3,102,927 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.37%
|
419,271
|
$2,821,694 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
344,391
|
$2,317,751 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.3%
|
344,051
|
$2,315,463 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
340,103
|
$2,288,893 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.24%
|
271,130
|
$1,824,705 | — | 31 Mar 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.23%
|
263,867
|
$1,844,430 | — | 31 Mar 2025 | |
| Exome Asset Management LLC |
13F
|
Company |
0.23%
|
263,841
|
$1,775,650 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
239,940
|
$1,614,796 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.2%
|
224,240
|
$1,509,135 | — | 31 Mar 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.18%
|
200,000
|
$1,346,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
193,302
|
$1,300,923 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
193,147
|
$1,299,879 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.16%
|
179,232
|
$1,206,231 | — | 31 Mar 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.14%
|
153,500
|
$1,033,055 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.13%
|
153,011
|
$1,029,764 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
145,016
|
$975,958 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
128,000
|
$861,440 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
126,579
|
$851,877 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
116,000
|
$780,680 | — | 31 Mar 2025 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.09%
|
102,475
|
$689,657 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
102,153
|
$687,000 | — | 31 Mar 2025 |
Institutional Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q2 2025
As of 30 Jun 2025,
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,431,966 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., FMR LLC, BlackRock, Inc., Redmile Group, LLC, ENAVATE SCIENCES GP, LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, EcoR1 Capital, LLC, Opaleye Management Inc., and PRIMECAP MANAGEMENT CO/CA/.
This page lists
142
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
141
Q2 2025 holders
142
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.